What is Zacks Research's Forecast for MMSI FY2025 Earnings?

Merit Medical Systems, Inc. (NASDAQ:MMSI - Free Report) - Equities researchers at Zacks Research dropped their FY2025 earnings estimates for Merit Medical Systems in a research report issued to clients and investors on Tuesday, March 18th. Zacks Research analyst I. Bandyopadhyay now forecasts that the medical instruments supplier will post earnings of $3.67 per share for the year, down from their previous estimate of $3.70. The consensus estimate for Merit Medical Systems' current full-year earnings is $3.37 per share.

Other research analysts have also recently issued research reports about the company. Canaccord Genuity Group dropped their price target on Merit Medical Systems from $128.00 to $127.00 and set a "buy" rating on the stock in a report on Wednesday, February 26th. Barrington Research reduced their target price on Merit Medical Systems from $115.00 to $111.00 and set an "outperform" rating for the company in a report on Wednesday, February 26th. Needham & Company LLC dropped their price target on Merit Medical Systems from $122.00 to $116.00 and set a "buy" rating on the stock in a research note on Wednesday, February 26th. Wells Fargo & Company reduced their price objective on shares of Merit Medical Systems from $120.00 to $117.00 and set an "overweight" rating for the company in a research note on Wednesday, February 26th. Finally, Raymond James lifted their target price on shares of Merit Medical Systems from $105.00 to $110.00 and gave the stock an "outperform" rating in a research report on Tuesday, December 31st. Two equities research analysts have rated the stock with a hold rating, eight have assigned a buy rating and one has assigned a strong buy rating to the stock. Based on data from MarketBeat.com, the stock has a consensus rating of "Moderate Buy" and an average target price of $110.78.

Remove Ads

Merit Medical Systems Price Performance

MMSI stock traded up $0.06 on Friday, hitting $104.74. 548,986 shares of the company's stock traded hands, compared to its average volume of 424,964. The stock has a market cap of $6.16 billion, a price-to-earnings ratio of 51.34, a P/E/G ratio of 2.34 and a beta of 0.91. Merit Medical Systems has a 1-year low of $70.70 and a 1-year high of $111.45. The company has a current ratio of 5.36, a quick ratio of 3.82 and a debt-to-equity ratio of 0.57. The stock has a fifty day moving average of $104.21 and a 200-day moving average of $100.92.

Insider Buying and Selling at Merit Medical Systems

In related news, CEO Fred P. Lampropoulos sold 31,320 shares of the business's stock in a transaction that occurred on Wednesday, March 5th. The stock was sold at an average price of $103.86, for a total value of $3,252,895.20. Following the completion of the sale, the chief executive officer now owns 1,086,028 shares of the company's stock, valued at approximately $112,794,868.08. The trade was a 2.80 % decrease in their position. The sale was disclosed in a filing with the SEC, which can be accessed through this link. Also, insider Brian G. Lloyd sold 25,000 shares of Merit Medical Systems stock in a transaction that occurred on Friday, February 28th. The shares were sold at an average price of $99.50, for a total transaction of $2,487,500.00. Following the completion of the sale, the insider now owns 38,993 shares of the company's stock, valued at $3,879,803.50. This trade represents a 39.07 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last quarter, insiders have sold 109,132 shares of company stock worth $11,139,521. 3.70% of the stock is currently owned by company insiders.

Institutional Inflows and Outflows

Hedge funds and other institutional investors have recently modified their holdings of the business. NewSquare Capital LLC acquired a new position in Merit Medical Systems during the fourth quarter worth $32,000. Kohmann Bosshard Financial Services LLC bought a new stake in shares of Merit Medical Systems during the 4th quarter worth about $52,000. Federated Hermes Inc. increased its holdings in shares of Merit Medical Systems by 139.1% during the 4th quarter. Federated Hermes Inc. now owns 655 shares of the medical instruments supplier's stock valued at $63,000 after acquiring an additional 381 shares during the last quarter. Group One Trading LLC bought a new position in shares of Merit Medical Systems in the 4th quarter valued at approximately $77,000. Finally, Harvest Fund Management Co. Ltd acquired a new stake in Merit Medical Systems in the 3rd quarter worth approximately $120,000. Institutional investors own 99.66% of the company's stock.

Merit Medical Systems Company Profile

Merit Medical Systems, Inc designs, develops, manufactures, and markets single-use medical products for interventional, diagnostic, and therapeutic procedures in the United States and internationally. It operates in two segments, Cardiovascular and Endoscopy. The company provides micropuncture kits, angiographic needles, sheaths, guide wires, and safety products; peripheral intervention, including angiography, drainage, delivery systems, and embolotherapy products; spine products, such as vertebral augmentation, radiofrequency ablation, and bone biopsy systems; oncology products; and cardiac intervention products, such as access, angiography, electrophysiology and cardiac rhythm management, fluid management, hemodynamic monitoring, hemostasis, and intervention to treat various heart conditions.